Almirall completes EU regulatory procedure for antifungal Jublia

Almirall has completed the decentralised regulatory procedure in Europe for efinaconazole to treat onychomycosis.

Oct 16, 2024 - 04:00

Almirall completes EU regulatory procedure for antifungal Jublia

Almirall has completed the decentralised regulatory procedure in Europe for efinaconazole to treat onychomycosis.

Read the original article

Tags:

Previous Article

The science of viscous drug product filling: Pumps, pressure, and process optimi...

Parenteral Solutions in Contract Manufacturing for the Pharmaceutical Industry

What's Your Reaction?

0

Like

0

Dislike

0

Love

0

Funny

0

Angry

0

Sad

0

Wow

Related Posts

Drug shortages challenge type 2 diabetes patients in the UK

Drug shortages challenge type 2 diabetes patients in th...

Jan 27, 2024

RespireRx and UCL partner to study AMPAkines for GRIA Disorder

RespireRx and UCL partner to study AMPAkines for GRIA D...

Apr 6, 2023

STAT+: FDA panel endorses Alnylam’s heart drug — after picking apart its supporting data

STAT+: FDA panel endorses Alnylam’s heart drug — after ...

Sep 14, 2023